2型糖尿病患者视盘周围视网膜神经纤维层厚度的纵向变化
这项前瞻性纵向观察研究纳入63名健康对照和101例2型糖尿病患者(49例无糖尿病视网膜病变,52例轻中度非增殖性糖尿病视网膜病变),随访3年并按年测量视盘周围视网膜神经纤维层厚度。线性混合模型显示无糖尿病视网膜病变组和糖尿病视网膜病变组年丢失量分别为-0.92 μm/年和-1.16 μm/年,均显著大于对照组的-0.35 μm/年,提示2型糖尿病与视盘周围视网膜神经纤维层丢失增加相关,无论是否伴糖尿病视网膜病变。
要点
- 2型糖尿病无糖尿病视网膜病变组视盘周围视网膜神经纤维层年丢失量为-0.92 μm/年。
- 轻中度非增殖性糖尿病视网膜病变组年丢失量为-1.16 μm/年,对照组为-0.35 μm/年。
- 2型糖尿病与视盘周围视网膜神经纤维层丢失增加相关,无论是否伴糖尿病视网膜病变。
核心结论
- 健康对照和伴或不伴糖尿病视网膜病变的2型糖尿病患者均观察到视盘周围视网膜神经纤维层厚度进行性变薄,但2型糖尿病与更大的视盘周围视网膜神经纤维层丢失相关,无论是否存在糖尿病视网膜病变。
- 这些发现提示2型糖尿病患者即使没有糖尿病视网膜病变进展,也可能发生视盘周围视网膜神经纤维层丢失。
研究设计与样本
- 前瞻性纵向观察研究,2013年1月2日至2015年2月27日纳入63名健康个体的164只眼和101例2型糖尿病患者的眼(49例无糖尿病视网膜病变,52例轻中度非增殖性糖尿病视网膜病变)。
- 参与者随访3年,每1年测量视盘周围平均及分区视网膜神经纤维层厚度,采用线性混合模型估计平均丢失率并比较3组。
- 随访于2018年3月16日完成,数据分析于2018年4月2日至7月27日进行。
主要发现
- 共164名参与者(88名女性[53.7%];平均[SD]年龄58.2[8.7]岁)纳入分析;对照组平均[SD]年龄56.5[9.3]岁(39名女性[61.9%]),无糖尿病视网膜病变组59.1[9.4]岁(26名女性[53.1%]),非增殖性糖尿病视网膜病变组59.4[11.0]岁(23名女性[44.2%])。
- 2型糖尿病平均[SD]病程在无糖尿病视网膜病变组为7.1[4.4]年,在非增殖性糖尿病视网膜病变组为13.2[8.4]年。
- 基线平均[SD]视盘周围视网膜神经纤维层厚度在对照组为96.2[11.0] μm,无糖尿病视网膜病变组为93.5[6.4] μm,非增殖性糖尿病视网膜病变组为90.4[7.9] μm;随访3年分别降至95.0[9.2] μm、90.3[6.4] μm和86.6[7.9] μm。
- 线性混合模型估计平均视盘周围视网膜神经纤维层丢失在无糖尿病视网膜病变组为-0.92 μm/年(P < .001),在非增殖性糖尿病视网膜病变组为-1.16 μm/年(P < .001),分别比对照组(-0.35 μm/年;P = .01)大2.9倍(95%CI,1.1-14.8;P = .003)和3.3倍(95%CI,1.4-18.0;P < .001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Type 2 diabetes is expected to accelerate age-related peripapillary retinal nerve fiber layer (pRNFL) loss, but limited information on the rate of reduction in pRNFL thicknesses in patients with type 2 diabetes is available. OBJECTIVE: To investigate longitudinal changes in pRNFL thickness in patients with type 2 diabetes, with or without diabetic retinopathy (DR). DESIGN, SETTING, AND PARTICIPANTS: A total of 164 eyes of 63 healthy individuals and 101 patients with type 2 diabetes (49 patients without DR [non-DR group] and 52 patients with mild to moderate nonproliferative DR [NPDR group]) were enrolled in this prospective, longitudinal, observational study from January 2, 2013, through February 27, 2015. Participants were followed up for 3 years, and the peripapillary mean and sector RNFL thicknesses were measured at 1-year intervals. The mean rate of pRNFL loss was estimated using a linear mixed model and compared among the 3 groups. Follow-up was completed on March 16, 2018, and data were analyzed from April 2 through July 27, 2018. EXPOSURE: Type 2 diabetes. MAIN OUTCOMES AND MEASURES: The rate of reduction in pRNFL thickness in patients with type 2 diabetes. RESULTS: A total of 164 participants (88 women [53.7%]; mean [SD] age, 58.2 [8.7] years) were included in the study analysis. The mean (SD) age of the control group was 56.5 (9.3) years (39 women [61.9%]); the non-DR group, 59.1 (9.4) years (26 women [53.1%]); and the NPDR group, 59.4 (11.0) years (23 women [44.2%]). Mean (SD) duration of type 2 diabetes was 7.1 (4.4) years in the non-DR group and 13.2 (8.4) years in the NPDR group. The baseline mean (SD) pRNFL thickness was 96.2 (11.0) μm in the control group, 93.5 (6.4) μm in the non-DR group, and 90.4 (7.9) μm in the NPDR group. During 3 years of follow-up, these values decreased to 95.0 (9.2) μm in the control group, 90.3 (6.4) in the non-DR group, and 86.6 (7.9) μm in the NPDR group. In a linear mixed model, the estimated mean pRNFL loss was -0.92 μm/y in the non-DR group (P < .001) and -1.16 μm/y in the NPDR group (P < .001), which was 2.9-fold (95% CI, 1.1-14.8; P = .003) and 3.3-fold (95% CI, 1.4-18.0; P < .001) greater, respectively, than that of the control group (-0.35 μm/y; P = .01). CONCLUSIONS AND RELEVANCE: Progressive reduction of pRNFL thickness was observed in healthy controls and patients with type 2 diabetes without and with DR; however, type 2 diabetes was associated with a greater loss of pRNFL regardless of whether DR was present. These findings suggest that pRNFL loss may occur in people with type 2 diabetes even in the absence of DR progression.
引用
- Lim HB, Shin YI, Lee MW, et al. Longitudinal Changes in the Peripapillary Retinal Nerve Fiber Layer Thickness of Patients With Type 2 Diabetes. JAMA Ophthalmol. 2019. PMID: 31343674. doi:10.1001/jamaophthalmol.2019.2537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。